SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-23-001011
Filing Date
2023-02-10
Accepted
2023-02-10 13:18:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 KYNAM CAPITAL MANAGEMENT, LP olma_21023.htm SC 13G 42549
  Complete submission text file 0001085146-23-001011.txt   43990
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91849 | Film No.: 23610124
SIC: 2834 Pharmaceutical Preparations

Mailing Address 221 ELM ROAD PRINCETON NJ 08540
Business Address 221 ELM ROAD PRINCETON NJ 08540 212-659-3970
Kynam Capital Management, LP (Filed by) CIK: 0001907884 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G